Introduction
The majority of strokes are now ischemic and caused mainly by acute thromboembolic arterial occlusion. New treatments have been attempted using thrombolytic agents by intravenous or intra-arterial injection 2. A favorable long-term prognosis was shown by intravenous thrombolytic treatment only when initiated very early 3. Intra-arterial thrombolysis is enhanced to be more effective than intravenous therapy 7. Currently, the time from the onset of cerebral embolism to the start of treatment is the most important factor determining prognosis. For patients with cerebral embolism, at first we revascularize the more peripheral brain tissues far from the thrombus, proceeding the microcatheter beyond the thrombus, and dissolving the thrombus using a satisfactory time as required. The unique features of the new system and our clinical experience of using it are described here.
Material and Methods
If the stroke patient is suspected of having cerebral embolism from their past history and the pattern of onset, angiography is performed immediately to determine the diagnosis. If the cerebral embolism is confirmed by angiography, introducers of 6F are inserted into the bilateral femoral arteries, and then systemic heparinization is started.
An introducer is used for guiding the catheter and a micro catheter is advanced into Figure 1 A typical diagram of a pump system. more peripheral portions of the artery piercing the thrombus using a guidewire. By superselective angiography with the microcatheter, we can confirm the length of the thrombus and that there are no thrombi in more peripheral parts. The blood-collecting side of the extracorporeal pump is connected to the side tube of the contralateral introducer, and the blood-feeding side of the pump is connected to the valve of the indwelling micro catheter. Then the pump action of feeding the arterial blood is started in order to relieve the ischemic state in the perfusion area (figure 1). Afterwards, thrombolysis is started by administering the tissue plasminogen activator (tPA) or urokinase from the arterial or venous route till the recanarization of the occluded artery is shown in DSA. Pump flow is also stopped after recanarization. If the postoperative eT shows no hemorrhagic infarction, the total heparinization will be continued for 3 days.
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Case Report
History: This 57-year-old man experienced a sudden onset of left hemiparesis whilst enjoying company after supper and was transferred to our hospital's emergency room by his daughter who is a nurse at our hospital. Ten years earlier, he had undergone mitral valve replacement surgery and is now controlled by warfarin.
Examination, treatment and result: One hour after the onset, rt. carotid angiography was performed representing an occlusion of the right middle cerebral artery at the Ml portion. Immediately, a microcatheter (110 cm, Fastracker 18, Boston) was advanced into the distal portion of the thrombus using the endovascular treatment technique. After confirmation that there were no other embolus at the more peripheral arteries, the extracorporeal pump that was set to revasculize the ischemic brain con- tinued thrombolysis using tPA, 1800000 ID from the guiding catheter and 1800000 ID from the microcatheter respectively. Several minutes after the beginning of the pump circulation, he improved in hemiparesis gradually. About 4 hours after onset, good revascuralization of the right middle cerebral artery was shown in angiography. One week after onset, a eT scan showed a small low-density area at the right basal ganglionic portion, but he was discharged and return to his job without neurological deficit 4.
Arterial blood flow and pump pressure
An arterial blood flow of at least 30 mllmin. in the middle cerebral artery is necessary to preserve brain tissues reversible from ischemic infarction. If the Ml portion of the middle cerebral artery was occluded by embolus, a collateral blood flow of 15 mllmin. remains at the least, therefore 15 mllmin of blood flow is necessary as a minimum. For this purpose, in the use of Tracker 18 (110 cm), pump pressure must be increased to 1,500 mmHg (about 2 atoms) because the blood is viscous. (figure 2)
Discussion
Individual good results of thrombolysis were reported in many papers, however there have been no statistical evaluations concerning the indication of this treatment and factors influencing the early recanalization. This treatment is based on three subjects as follows: a test to diagnose tissue viability, a treatment to prolong reversibility and a technique to provide rapid, high flow revascularization 1. Though various treatments have been attempted, no reliable method is yet available to solve this problem. Tissue viability is examined by measurement of the regional cerebral blood flow 8, and the dif-fusion weighted image of MRI within the super acute phase 6. The critical cerebral blood flow was thought to be below 30 mlll00g/min 9. Almost all high intensity areas on the diffusionweighted image will be obvious infarction. Urokinase, pro-urokinase and tPA are strong thrombolytic agents which is shown extensively elsewhere in the body8. However, the therapeutic windows in acute ischemic stroke of a major vessel in the anterior circulation is only 6 to 7 hours, so new neuronal protective agents or therapy must be developed 5. With our methods, even in the duration of occlusion by the embolus, the circulation of blood beyond the embolus is maintained and neurological improvement can be shown by the restoration of brain tissue. When the major artery was occluded, the blood flow which is necessary to protect brain tissue from change to infarction, depends on the remnant blood flow through the collateral ways. On the other hand, to make enough blood flow from the micro catheter, relatively high pump pressure is necessary for the blood viscosity because of the catheter's thinness. For example, in the case of the middle cerebral artery occlusion at the Ml portion, over 15mllmin. of arterial blood is necessary to protect the brain tissue, additional to the remnant flow of over 15mllmin .. One thousand and five hundred mmHg (about 2 atoms) of pump pressure is necessary to send 15mllmin. of blood through the micro catheter (110 cm, FastTrucker 18, Boston) (figure 2). It was confirmed by laboratory and clinical data that hemolysis by the pump action and by the flow through the thin catheter was not sufficient to aggravate kidney function.
Conclusion
This method enables the protection of brain tissues from irreversible change after cerebral embolism, and extends the time available for thrombolysis.
